The Multiple Sclerosis-Fatigue Self- Efficacy (MS-FSE) scale: initial validation.

Authors:
Thomas S; Kersten P; Thomas PW.

Journal:
Clin Rehabil

Publication Year: 2014

DOI:
10.1177/0269215514543702

PMCID:
PMC4390524

PMID:
25160009

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Rehabil

Abbreviation: Clin Rehabil

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Physical and Rehabilitation Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acceptance and commitment therapy for people with acquired brain injury: Rationale and description …
Rauwenhoff JC; Bol Y; van Heugten CM and 7 more (2023) - Transparency Score: 3/6
Acceptance and Commitment Therapy is feasible for people with acquired brain injury: A process eval…
Rauwenhoff JC; Bol Y; Peeters F and 1 more (2023) - Transparency Score: 4/6
Accuracy of a computer vision system for estimating biomechanical measures of body function in axia…
Cronin NJ; Mansoubi M; Hannink E and 2 more (2023) - Transparency Score: 4/6
A general theory of rehabilitation: Rehabilitation catalyses and assists adaptation to illness.
Wade DT. (2023) - Transparency Score: 3/6
A programme evaluation of 'First Steps': A peer-conceived, developed and led self-management interv…
Collett J; Lawrie S; Bromley S and 9 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: The authors declare that there is no conflict of interest."

Evidence found in paper:

"Funding: This research was funded by the Multiple Sclerosis Society in the UK (grant number 846/06). The FACETS trial is included in the National Institute of Health Research Clinical Research Network (NIHR CRN) portfolio (ID 4843) and the ISRCTN is 76517470."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025